Skip to main content
Swedish Orphan Biovitrum logo

Swedish Orphan Biovitrum — Investor Relations & Filings

Ticker · SOBI ISIN · SE0000872095 LEI · 549300124Y3MQI87PT35 ST Manufacturing
Open in API
Filings indexed 892 across all filing types
Latest filing 2018-06-21 Major Shareholding Noti…
Country SE Sweden
Listing ST SOBI

About Swedish Orphan Biovitrum

https://www.sobi.com/en

Swedish Orphan Biovitrum (Sobi) is a specialized biopharmaceutical company dedicated to developing and delivering innovative treatments for rare and debilitating diseases. The company's primary focus is on the therapeutic areas of haematology and immunology, with a significant legacy and continued leadership in haemophilia care. Sobi addresses the high unmet medical needs of patients by advancing a pipeline of innovative medicines and working to expand patient access globally. The company's mission is to transform the lives of people affected by rare conditions through dedicated research, development, and global collaboration.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding percentage for a specific holder ('Swedbank Robur Fonder AB') in an issuer ('Swedish Orphan Biovitrum AB (publ)'). It shows the 'Before the transaction' and 'After the transaction' share quantities and voting rights, culminating in a new percentage (4.96%). The section header 'Reason for major shareholding notification Sell' directly indicates this is a notification regarding a significant change in ownership. This aligns perfectly with the definition for Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2018-06-21 English
Kommuniké från Swedish Orphan Biovitrums (publ) (”Sobi”) årsstämma
AGM Information Classification · 100% confidence The document is explicitly titled "Kommuniké från Swedish Orphan Biovitrums (publ) ("Sobi") årsstämma" which translates to 'Communication from Swedish Orphan Biovitrum's (publ) ("Sobi") Annual General Meeting (AGM)'. It details the decisions made by shareholders regarding the approval of financial statements, election/re-election of board members, auditor appointment, and approval of remuneration guidelines and incentive programs. These are all core activities of an AGM. Therefore, the most appropriate classification is AGM Information (AGM-R).
2018-05-09 Swedish
Bulletin from Swedish Orphan Biovitrum’s (publ) (“Sobi’s”) Annual General Meeting (AGM)
AGM Information Classification · 100% confidence The document explicitly states it is a "Bulletin from Swedish Orphan Biovitrum's (publ) ('Sobi's') Annual General Meeting (AGM)" and details the resolutions voted upon, including the adoption of financial statements, election of the Board of Directors, and approval of remuneration and incentive programs. This content directly corresponds to the materials presented or concluded at an AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (5068 chars) is substantial enough to be the report/summary itself, not just a brief announcement of publication.
2018-05-09 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY – MARCH 2018' and contains comprehensive financial data, including income statements, revenue breakdowns by business area, and management commentary on performance for the first quarter of 2018. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2018
2018-04-26 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–March 2018. It contains detailed financial statements, performance analysis, business segment updates (Haemophilia and Specialty Care), and management commentary. It is a comprehensive quarterly report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). Q1 2018
2018-04-26 Swedish
Annual Report 2017
Annual Report Classification · 100% confidence The document is titled 'ÅRS- OCH HÅLLBARHETSREDOVISNING 2017' (Annual and Sustainability Report 2017) for the company Sobi. It contains comprehensive financial statements, management reports, board information, and audit details for the full fiscal year 2017. It is clearly the official annual report of the company, not an announcement or a summary. FY 2017
2018-04-17 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.